Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Materials (Basel) ; 16(14)2023 Jul 11.
Article in English | MEDLINE | ID: mdl-37512218

ABSTRACT

We derive the governing equations for the overall behaviour of linear viscoelastic composites comprising two families of elastic inclusions, subphases and/or fibres, and an incompressible Newtonian fluid interacting with the solid phases at the microscale. We assume that the distance between each of the subphases is very small in comparison to the length of the whole material (the macroscale). We can exploit this sharp scale separation and apply the asymptotic (periodic) homogenization method (AHM) which decouples spatial scales and leads to the derivation of the new homogenised model. It does this via upscaling the fluid-structure interaction problem that arises between the multiple elastic phases and the fluid. As we do not assume that the fluid flow is characterised by a parabolic profile, the new macroscale model, which consists of partial differential equations, is of Kelvin-Voigt viscoelastic type (rather than poroelastic). The novel model has coefficients that encode the properties of the microstructure and are to be computed by solving a single local differential fluid-structure interaction (FSI) problem where the solid and the fluid phases are all present and described by the one problem. The model reduces to the case described by Burridge and Keller (1981) when there is only one elastic phase in contact with the fluid. This model is applicable when the distance between adjacent phases is smaller than the average radius of the fluid flowing in the pores, which can be the case for various highly heterogeneous systems encountered in real-world (e.g., biological, or geological) scenarios of interest.

2.
Materials (Basel) ; 16(11)2023 May 25.
Article in English | MEDLINE | ID: mdl-37297108

ABSTRACT

We develop a general approach for the computation of the effective properties of nonlinear viscoelastic composites. For this purpose, we employ the asymptotic homogenisation technique to decouple the equilibrium equation into a set of local problems. The theoretical framework is then specialised to the case of a strain energy density of the Saint-Venant type, with the second Piola-Kirchhoff stress tensor also featuring a memory contribution. Within this setting, we frame our mathematical model in the case of infinitesimal displacements and employ the correspondence principle which results from the use of the Laplace transform. In doing this, we obtain the classical cell problems in asymptotic homogenisation theory for linear viscoelastic composites and look for analytical solutions of the associated anti-plane cell problems for fibre-reinforced composites. Finally, we compute the effective coefficients by specifying different types of constitutive laws for the memory terms and compare our results with available data in the scientific literature.

3.
Lancet Reg Health Am ; 12: 100273, 2022 Aug.
Article in English | MEDLINE | ID: mdl-36776424

ABSTRACT

Background: Difficulties associated with the assessment of glucose-6-phosphate dehydrogenase deficiency (G6PDd), particularly in remote areas, hinders the safe use of 8-aminoquinolines such as primaquine (PQ) and tafenoquine against Plasmodium vivax malaria due to the risk of haemolysis. Methods: This cross-sectional study was conducted in 41 malaria-endemic municipalities of six states in the Brazilian Amazon, between 2014 and 2018. Male individuals were screened for G6PDd using the qualitative Fluorescent Spot Test using fingerpick-collected whole blood samples. Point and interval estimates of the G6PDd prevalence were calculated for each state. Deficient samples were genotyped for the most prevalent variants in the Amazon. Frequencies of P. vivax malaria recurrences were estimated for G6PDd and non-G6PDd patients. Interpretation: This is one of the largest surveys ever conducted in Latin America, covering the entire malaria endemic area in the Brazilian Amazon. These results indicate that an important proportion of the population is at risk of hemolysis if exposed to PQ and its congener drug tafenoquine. The adoption of G6PDd screening protocols is essential to ensure the safety of individuals treated with those drugs and should also be considered when implementing malaria elimination strategies. Findings: A total of 14,847 individuals were included, of which 5.6% presented G6PDd. The state of Acre had the highest G6PDd prevalence (8.3%), followed by Amapá (5.8%), Pará (5.7%), Rondônia (5.4%), Roraima (4.2%) and Amazonas (4.0%). From 828 genotyped samples, African A+ (6.2%), African A- (39.3%) and wild-type (non-African non-Mediterranean; 54.2%) variants were found. A greater proportion of malaria recurrences was found among G6PD deficient individuals [16.7% vs 4.1%, Risk ratio 3.52 (2.16-5.74) p < 0.01]. Funding: Brazilian Ministry of Health; Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM).

4.
Reproduction ; 160(5): 673-684, 2020 11.
Article in English | MEDLINE | ID: mdl-33065547

ABSTRACT

During embryo implantation, endometrial angiogenesis is regulated by signals originating from the endometrium itself and the developing embryo. It has been suggested that hCG may play a pro-angiogenic role; therefore, we sought to understand its regulatory role in blood vessel formation in human endometrium using in vivo and in vitro models. In the in vivo model, we screened 16 angiogenesis-related transcripts in the endometrium upon intrauterine administration of hCG. Oocyte donors were recruited and during their controlled ovarian stimulation cycle received a single dose of hCG or vehicle on the day of oocyte pick up during a cycle of ovarian stimulation. One hour before obtaining an endometrial sample, women received an intrauterine administration of vehicle or hCG (500, 1500 and 5000 IU). Transcript and protein analysis showed that MMP3 and VEGFA increased, whereas TIMP1 decreased. The in vitro analysis studied the angiogenic potential of conditioned medium (CM) from primary cultures of human endometrial stromal cells (ESC) stimulated with hCG. Using a 2D and 3D in vitro angiogenesis assays, our results indicate that CM from ESC almost completely inhibits the capillary-like structure formation in endothelial cells, overriding the pro-angiogenic effect of hCG; and this inhibition due to secreted factors present in CM specifically reduced the migration potential of endothelial cells. In conclusion, the endometrial stromal milieu seems to modulate the direct pro-angiogenic effects of hCG on endothelial cells during embryo implantation.


Subject(s)
Chorionic Gonadotropin/administration & dosage , Endometrium/drug effects , Neovascularization, Physiologic/drug effects , Stromal Cells/drug effects , Adult , Blood Transfusion, Intrauterine , Cell Movement , Cells, Cultured , Endometrium/metabolism , Female , Human Umbilical Vein Endothelial Cells , Humans , In Vitro Techniques , Middle Aged , Stromal Cells/metabolism
5.
Materials (Basel) ; 12(2)2019 Jan 11.
Article in English | MEDLINE | ID: mdl-30641900

ABSTRACT

In this manuscript, the equilibrium problem for a flexoelectric one-dimensional composite material is studied. The two-scales asymptotic homogenization method is used to derive the homogenized formulation of this problem. The manuscript offers a step-by-step methodology to derive effective coefficients and to solve local problems. As an illustrative example, results reported in the literature for piezoelectric composites are obtained as a particular case of the formulation derived here. Finally, three flexoelectric/piezoelectric composites are studied to illustrate the influence of the flexoelectric property on the effective coefficients and the global behavior of the structure.

6.
J Theor Biol ; 426: 152-161, 2017 08 07.
Article in English | MEDLINE | ID: mdl-28552555

ABSTRACT

The present work focuses on the integration of analytical and numerical strategies to investigate the thermal distribution of cancerous breasts. Coupled stationary bioheat transfer equations are considered for the glandular and heterogeneous tumor regions, which are characterized by different thermophysical properties. The cross-section of the cancerous breast is identified by a homogeneous glandular tissue that surrounds the heterogeneous tumor tissue, which is assumed to be a two-phase periodic composite with non-overlapping circular inclusions and a square lattice distribution, wherein the constituents exhibit isotropic thermal conductivity behavior. Asymptotic periodic homogenization method is used to find the effective properties in the heterogeneous region. The tissue effective thermal conductivities are computed analytically and then used in the homogenized model, which is solved numerically. Results are compared with appropriate experimental data reported in the literature. In particular, the tissue scale temperature profile agrees with experimental observations. Moreover, as a novelty result we find that the tumor volume fraction in the heterogeneous zone influences the breast surface temperature.


Subject(s)
Breast Neoplasms/pathology , Models, Biological , Temperature , Female , Humans , Tumor Burden
7.
Mol Hum Reprod ; 23(6): 393-405, 2017 06 01.
Article in English | MEDLINE | ID: mdl-28333280

ABSTRACT

STUDY QUESTION: How does hCG signal in human endometrial stromal cells (ESCs) and what is its role in regulating ESC function? SUMMARY ANSWER: hCG signaling in ESCs activates the extracellular signal-regulated protein kinases 1 and 2 (Erk1/2) pathway through exchange protein activated by cyclic AMP (cAMP) (Epac) and transiently increases progesterone receptor (PR) transcript and protein expression and its transcriptional function. WHAT IS KNOWN ALREADY: hCG is one of the earliest embryo-derived secreted signals in the endometrium, which abundantly expresses LH/hCG receptors. hCG signals through cAMP/protein kinase A (PKA) in gonadal cells, but in endometrial epithelial cells, hCG induces Erk1/2 activation independent of the cAMP/PKA pathway. Few data exist concerning the signal transduction pathways triggered by hCG in ESCs and their role in regulation of ESC function. STUDY DESIGN, SIZE, DURATION: This is an in vitro study comprising patients undergoing benign gynecological surgery (n = 46). PARTICIPANTS/MATERIALS, SETTING, METHODS: Endometrial samples were collected from normal cycling women during the mid-secretory phase for ESCs isolation. The study conducted in an academic research laboratory within a tertiary-care hospital. The activation of the Erk1/2 signal transduction pathway elicited by hCG was evaluated in ESC. Signaling pathway inhibitors were used to examine the roles of PKA, PI3K, PKC, adenylyl cyclase and Epac on the hCG-stimulated up-regulation of phospho-Erk1/2 (pErk1/2). Erk1/2 phosphorylation was determined by immunoblot. siRNA targeting Epac was used to investigate the molecular mechanisms. To assess the role of Erk1/2 signaling induced by hCG on ESC function, gene expression regulation was examined by immunofluorescence and real-time quantitative PCR. The role of PR on the regulation of transcript levels was studied using progesterone and the PR antagonist RU486. All experiments were conducted using at least three different cell culture preparations in triplicate. MAIN RESULTS AND THE ROLE OF CHANCE: Addition of hCG to ESCs in vitro induced the phosphorylation of Erk1/2 through cAMP accumulation. Such induction could not be blocked by inhibitors for PKA, PKC and PI3K. Epac inhibition and knockdown with siRNA prevented pErk1/2 induction by hCG. ESCs stimulated with hCG for up to 72 h showed a significant increase in PR mRNA and immunofluorescent label at 48 h only; an effect that was abrogated with the mitogen-activated protein kinase kinase inhibitor UO126. In addition, the hCG-activated Erk1/2 pathway significantly decreased the mRNA levels for secreted frizzled-related protein 4 (SFRP4) at 24 h, whereas it increased those for homeobox A10 (HOXA10) at 48 h (P = 0.041 and P = 0.022 versus control, respectively). Prolactin mRNA levels were not significantly modified. HOXA10 mRNA up-regulation by hCG was not enhanced by co-stimulation with progesterone; however, it was completely abolished in the presence of RU486 (P = 0.036 hCG versus hCG + RU486). LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: This is an in vitro study utilizing stromal cell cultures from human endometrial tissues. Furthermore, results obtained should also be confirmed in vivo in the context of the whole human endometrial tissue and hormonal milieu. The in vitro experiments using hCG have been conducted without other hormones/factors that may also modulate the ESCs response to hCG. WIDER IMPLICATIONS OF THE FINDINGS: We have determined that hCG induces the PR through the Erk1/2 pathway in ESCs which may render them more sensitive to progesterone, increasing our understanding about the effects of hCG at the embryo-maternal interface. The activation of such a pathway in the context of the hormonal milieu during the window of implantation might contribute to a successful dialog between the embryo and the uterus, leading to appropriate endometrial function. Defective hCG signaling in the endometrial stromal tissue may lead to an incomplete uterine response, compromising embryo implantation and early pregnancy. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Fund for Scientific and Technological Development, Government of Chile (FONDECYT) grants 11100443 and 1140614 (A.T.-P.). The authors have no conflicts of interest to declare.


Subject(s)
Chorionic Gonadotropin/pharmacology , Guanine Nucleotide Exchange Factors/genetics , Mitogen-Activated Protein Kinase 1/genetics , Mitogen-Activated Protein Kinase 3/genetics , Receptors, Progesterone/genetics , Stromal Cells/drug effects , Adenylyl Cyclases/genetics , Adenylyl Cyclases/metabolism , Adult , Cyclic AMP-Dependent Protein Kinases/genetics , Cyclic AMP-Dependent Protein Kinases/metabolism , Endometrium/cytology , Endometrium/drug effects , Endometrium/metabolism , Female , Gene Expression Regulation, Developmental , Guanine Nucleotide Exchange Factors/agonists , Guanine Nucleotide Exchange Factors/metabolism , Homeobox A10 Proteins , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Pregnancy , Primary Cell Culture , Protein Kinase C/genetics , Protein Kinase C/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Receptors, Progesterone/metabolism , Signal Transduction , Stromal Cells/cytology , Stromal Cells/metabolism , Transcription, Genetic
8.
Fertil Steril ; 106(2): 393-401, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27117373

ABSTRACT

OBJECTIVE: To evaluate divalent metal transporter-1 (DMT1) expression in healthy women's and endometriosis patients' endometrium and to analyze DMT1 and ferritin light chain (Fn-L) expression modulation by iron overload and IL-1ß in endometrial stromal cells (ESCs). DESIGN: Observational and experimental study. SETTING: University hospital research laboratory. PATIENT(S): Thirty-one healthy women and 24 endometriosis patients. INTERVENTION(S): Menstrual, proliferative, and secretory endometrial biopsies. Isolated ESCs from seven endometrial biopsies incubated with IL-1ß or FeSO4 overload for 24 hours. MAIN OUTCOME MEASURE(S): Divalent metal transporter-1 endometrial protein expression assessed by immunohistochemistry and Western blot. Divalent metal transporter-1 and Fn-L proteins expression in stimulated ESCs evaluated by Western blot. RESULT(S): Divalent metal transporter-1 is expressed throughout the menstrual cycle in human endometrium. Four endometrial DMT1 variants were identified accordingly to their molecular weight: DMT-80, -65, -55, and -50. Endometrial expression of DMT-80 and -55 is higher in endometriosis patients than in healthy women. In ESCs, iron overload induces an overexpression of DMT-80, DMT-50, and Fn-L, whereas IL-1ß increases DMT-80 and -50 expressions and decreases Fn-L expression. CONCLUSION(S): Divalent metal transporter-1 overexpression in endometriosis patients' endometrium can increase iron influx to endometrial cells, inducing oxidative stress-mediated proinflammatory signaling. In turn, endometriosis-related conditions, as iron overload and inflammation (IL-1ß), enhance endometriosis patients endometrial DMT1 expression, creating a vicious circle on DMT-1-modulated pathways.


Subject(s)
Cation Transport Proteins/metabolism , Endometriosis/metabolism , Endometrium/metabolism , Stromal Cells/metabolism , Apoferritins/metabolism , Biopsy , Case-Control Studies , Endometriosis/pathology , Endometriosis/physiopathology , Endometrium/drug effects , Endometrium/pathology , Endometrium/physiopathology , Female , Ferrous Compounds/pharmacology , Humans , Inflammation/metabolism , Inflammation/pathology , Inflammation Mediators/metabolism , Interleukin-1beta/pharmacology , Iron Overload/metabolism , Iron Overload/pathology , Menstrual Cycle , Oxidative Stress , Signal Transduction , Stromal Cells/drug effects , Stromal Cells/pathology , Tissue Culture Techniques
9.
Biol Res ; 48: 56, 2015 Oct 09.
Article in English | MEDLINE | ID: mdl-26453052

ABSTRACT

BACKGROUND: Endometriosis, pro-inflammatory and invasive benign disease estrogen dependent, abnormally express in endometria the enzyme P450Arom, positively regulated by steroid factor-1 (SF-1). Our objective was to study the nuclear protein contents of upstream stimulating factor 2 (USF2a and USF2b), a positive regulator of SF-1, throughout the menstrual cycle in eutopic endometria from women with and without (control) endometriosis and the involvement of nuclear estrogen receptors (ER) and G-coupled protein estrogen receptor (GPER)-1. RESULTS: Upstream stimulating factor 2 protein contents were higher in mid (USF2b) and late (USF2a and USF2b) secretory phase in eutopic endometria from endometriosis than control (p < 0.05). In isolated control epithelial cells incubated with E2 and PGE2, to resemble the endometriosis condition, the data showed: (a) significant increase of USF2a and USF2b nuclear protein contents when treated with E2, PPT (specific agonist for ERα) or G1 (specific agonist for GPER1); (b) no increase in USF2 binding to SF-1 E-Box/DNA consensus sequence in E2-treated cells; (c) USF2 variants protein contents were not modified by PGE2; (d) SF-1 nuclear protein content was significantly higher than basal when treated with PGE2, E2 or G1, stimulation unaffected by ICI (nuclear ER antagonist); and (e) increased (p < 0.05) cytosolic protein contents of P450Arom when treated with PGE2, E2, PPT or G1 compared to basal, effect that was additive with E2 + PGE2 together. Nevertheless, in endometriosis cells, the high USF2, SF-1 and P450Arom protein contents in basal condition were unmodified. CONCLUSION: These data strongly suggest that USF2 variants and P450Arom are regulated by E2 through ERα and GPER1, whereas SF-1 through GPER1, visualized by the response of the cells obtained from control endometria, being unaffected the endogenously stimulated cells from endometriosis origin. The lack of E2 stimulation on USF2/SF-1 E-Box/DNA-sequence binding and the absence of PGE2 effect on USF2 variants opposite to the strong induction that they exert on SF1 and P450 proteins suggest different mechanisms and indirect regulations. The sustained USF2 variants protein expression during the secretory phase in eutopic endometria from women with endometriosis may participate in the pathophysiology of this disease strongly associated with infertility and its characteristic endometrial invasion to ectopic sites in the pelvic cavity.


Subject(s)
Aromatase/metabolism , Endometriosis/metabolism , Endometrium/metabolism , Estradiol/metabolism , Gene Expression/genetics , Upstream Stimulatory Factors/metabolism , Adult , Biopsy , Endometriosis/pathology , Endometriosis/physiopathology , Endometrium/cytology , Epithelial Cells/metabolism , Female , Humans , Immunoblotting , Menstrual Cycle/metabolism , Primary Cell Culture , Statistics, Nonparametric
10.
Fertil Steril ; 103(2): 439-47, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25500022

ABSTRACT

OBJECTIVE: To evaluate the effect of iron overload on nuclear factor kappa-B (NF-κB) activation in human endometrial stromal cells (ESCs). DESIGN: Experimental study. SETTING: University hospital research laboratory. PATIENT(S): Ten healthy women. INTERVENTION(S): Isolated ESCs from endometrial biopsies were incubated with 50 µM FeSO(4) or vehicle. The NF-κB inhibitor [5-(p-fluorophenyl)-2-ureido] thiophene-3-carboxamide (TPCA-1), which inhibits IKKß, the kinase of IκBα (inhibitory protein of NF-κB), was used to prevent iron overload-stimulated NF-κB changes in ESCs. MAIN OUTCOME MEASURE(S): NF-κB activation was assessed by p65:DNA-binding activity immunodetection assay. IκBα, p65, and intercellular adhesion molecule (ICAM)-1 proteins expression was evaluated by Western blots. ESC soluble ICAM (sICAM)-1 secretion was measured by ELISA using conditioned medium. RESULT(S): Iron overload increased p65:DNA-binding activity and decreased IκBα and p65 cytoplasmic expression in ESCs after 30 minutes of incubation as compared with the basal condition. ESC ICAM-1 expression and sICAM-1 secretion were higher after 24 hours of iron overload treatment than in the absence of treatment. TPCA-1 prevented the iron overload-induced increase of p65:DNA binding and IκBα degradation. CONCLUSION(S): Iron overload activates IKKß in ESCs, stimulating the NF-κB pathway and increasing ICAM-1 expression and sICAM-1 secretion. These results suggest that iron overload induces a proendometriotic phenotype on healthy ESCs, which could participate in endometriosis pathogenesis and development.


Subject(s)
Endometriosis/metabolism , Endometrium/cytology , Endometrium/metabolism , Iron Overload/metabolism , NF-kappa B/metabolism , Adult , Amides/pharmacology , Cells, Cultured , Endometriosis/chemically induced , Endometrium/drug effects , Female , Ferric Compounds/toxicity , Humans , Iron Overload/chemically induced , NF-kappa B/antagonists & inhibitors , Stromal Cells/drug effects , Stromal Cells/metabolism , Thiophenes/pharmacology
11.
Biol. Res ; 48: 1-11, 2015. graf
Article in English | LILACS | ID: biblio-950820

ABSTRACT

BACKGROUND: Endometriosis, pro-inflammatory and invasive benign disease estrogen dependent, abnormally express in endometria the enzyme P450Arom, positively regulated by steroid factor-1 (SF-1). Our objective was to study the nuclear protein contents of upstream stimulating factor 2 (USF2a and USF2b), a positive regulator of SF-1, throughout the menstrual cycle in eutopic endometria from women with and without (control) endometriosis and the involvement of nuclear estrogen receptors (ER) and G-coupled protein estrogen receptor (GPER)-1. RESULTS: Upstream stimulating factor 2 protein contents were higher in mid (USF2b) and late (USF2a and USF2b) secretory phase in eutopic endometria from endometriosis than control (p < 0.05). In isolated control epithelial cells incubated with E2 and PGE2, to resemble the endometriosis condition, the data showed: (a) significant increase of USF2a and USF2b nuclear protein contents when treated with E2, PPT (specific agonist for ERa) or G1 (specific agonist for GPER1); (b) no increase in USF2 binding to SF-1 E-Box/DNA consensus sequence in E2-treated cells; (c) USF2 variants protein contents were not modified by PGE2; (d) SF-1 nuclear protein content was significantly higher than basal when treated with PGE2, E2 or G1, stimulation unaffected by ICI (nuclear ER antagonist); and (e) increased (p < 0.05) cytosolic protein contents of P450Arom when treated with PGE2, E2, PPT or G1 compared to basal, effect that was additive with E2 + PGE2 together. Nevertheless, in endometriosis cells, the high USF2, SF-1 and P450Arom protein contents in basal condition were unmodified. CONCLUSION: These data strongly suggest that USF2 variants and P450Arom are regulated by E2 through ERa and GPER1, whereas SF-1 through GPER1, visualized by the response of the cells obtained from control endometria, being unaffected the endogenously stimulated cells from endometriosis origin. The lack of E2 stimulation on USF2/SF-1 E-Box/DNA-sequence binding and the absence of PGE2 effect on USF2 variants opposite to the strong induction that they exert on SF1 and P450 proteins suggest different mechanisms and indirect regulations. The sustained USF2 variants protein expression during the secretory phase in eutopic endometria from women with endometriosis may participate in the pathophysiology of this disease strongly associated with infertility and its characteristic endometrial invasion to ectopic sites in the pelvic cavity.


Subject(s)
Humans , Female , Adult , Aromatase/metabolism , Gene Expression/genetics , Endometriosis/metabolism , Endometrium/metabolism , Estradiol/metabolism , Biopsy , Immunoblotting , Statistics, Nonparametric , Endometriosis/physiopathology , Endometriosis/pathology , Endometrium/cytology , Epithelial Cells/metabolism , Primary Cell Culture , Menstrual Cycle/metabolism
12.
Biotechnol Prog ; 29(1): 17-22, 2013.
Article in English | MEDLINE | ID: mdl-23125137

ABSTRACT

Magainin-2 (MAG2) is a polycationic antimicrobial peptide isolated from the skin of the African clawed frog Xenopus laevis. It has a wide spectrum of antimicrobial activities against gram-positive and gram-negative bacteria, fungi, and induces osmotic lysis of protozoa. MAG2 also possesses antiviral and antitumoral properties. These activities make this peptide a promising candidate for therapeutic applications. Recombinant expression systems are necessary for the affordable production of large amounts of the biologically active peptide. In this work, MAG2 has been cloned to the N-terminal of a family III carbohydrate-binding module fused to the linker sequence (LK-CBM3) from Clostridium thermocellum; a formic acid recognition site was introduced between the two modules for chemical cleavage of the peptide. The recombinant protein MAG2-LK-CBM3 was expressed in Escherichia coli BL21 (DE3) and MAG2 was successfully cleaved and purified from the fusion partner LK-CBM3. Its functionality was confirmed by testing its activity against gram-negative bacteria.


Subject(s)
Magainins/genetics , Magainins/isolation & purification , Xenopus Proteins/genetics , Xenopus Proteins/isolation & purification , Animals , Escherichia coli/genetics , Escherichia coli/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Xenopus laevis/genetics , Xenopus laevis/metabolism
13.
Fertil Steril ; 98(3): 520-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22771029

ABSTRACT

OBJECTIVE: To update, analyze, and summarize the literature concerning nuclear factor-kappaB (NF-κB) participation in endometriosis pathophysiology. DESIGN: Review. RESULT(S): Nuclear factor-kappaB is physiologically activated in the human endometrium, showing variable activity. A cyclic p65-DNA binding pattern was shown in the endometrium of healthy women. This cyclic pattern was altered in the endometrium of patients with endometriosis. Nuclear factor-kappaB is basally activated in peritoneal endometriotic lesions, showing higher p65 activity in red endometriotic lesions than in black lesions. In vivo and in vitro studies show up-regulation of inflammation and cell proliferation and down-regulation of apoptosis by NF-κB activity. Iron overload has been shown in the pelvic cavity of endometriosis patients, and iron overload and oxidative stress activate NF-κB in macrophages, which have been shown to participate in the endometriosis-associated inflammatory reaction. CONCLUSION(S): Nuclear factor-kappaB activation dysregulation in the endometrium of endometriosis patients may explain some endometrial biological alterations associated with endometriosis. The scientific evidence strongly suggests that NF-κB activity in endometriotic cells stimulates inflammation and cell proliferation and inhibits apoptosis, favoring the development and maintenance of endometriosis. Iron overload in the pelvic cavity of endometriosis patients could be a main factor enhancing oxidative stress and activating NF-κB in a chronic manner, contributing to endometriosis establishment and growth.


Subject(s)
Endometriosis/etiology , Inflammation/etiology , NF-kappa B/physiology , Animals , Apoptosis , Cell Proliferation , Cell Survival , Endometriosis/physiopathology , Female , Humans , Iron/metabolism
14.
Fertil Steril ; 97(3): 645-51, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22196717

ABSTRACT

OBJECTIVE: To evaluate nuclear factor kappaB (NF-κB) activation and NF-κB-p65 subunit activation, immunolocalization, and expression in the endometrium of healthy women and endometriosis patients throughout the menstrual cycle. DESIGN: Prospective observational study. SETTING: Affiliated hospital and university research laboratory. PATIENT(S): Twenty-four healthy women and 24 endometriosis patients. INTERVENTION(S): Menstrual, proliferative, and secretory endometrial biopsies. MAIN OUTCOME MEASURE(S): Assessment of NF-κB and p65 activation by protein-DNA binding assays and p65 localization and expression by immunohistochemistry. RESULT(S): Total NF-κB-DNA binding was constitutive and variable in human endometrium accross the menstrual cycle. Healthy women (physiologic conditions) showed higher p65-DNA binding in proliferative than in menstrual and secretory endometrium. Conversely, in endometriosis patients, p65-DNA binding was higher in proliferative and secretory endometrium than in menstrual endometrium. Endometrial epithelial cells showed higher p65 expression level score than endometrial stromal cells. CONCLUSION(S): NF-κB activity is constitutive, physiologic, and variable in human endometrium. The physiologic cyclic p65 activation pattern was altered in endometriosis patients, showing no cyclic variation between the proliferative and secretory phase of the menstrual cycle. The absence of decreased p65 activity in secretory endometrium from endometriosis patients is concurrent with progesterone resistance and could participate in endometrial biologic alterations during the implantation window in endometriosis patients.


Subject(s)
Endometriosis/metabolism , Endometrium/metabolism , Menstrual Cycle/metabolism , NF-kappa B/metabolism , Adult , Binding Sites , Biopsy , Case-Control Studies , Chile , DNA/metabolism , Electrophoretic Mobility Shift Assay , Endometriosis/pathology , Endometrium/pathology , Epithelial Cells/metabolism , Female , Follicular Phase/metabolism , Humans , Immunohistochemistry , Luteal Phase/metabolism , Menstruation/metabolism , Middle Aged , Prospective Studies , Stromal Cells/metabolism , Transcription Factor RelA/metabolism , Young Adult
15.
Front Biosci (Elite Ed) ; 4(1): 23-40, 2012 01 01.
Article in English | MEDLINE | ID: mdl-22201853

ABSTRACT

Peritoneal endometriosis is a chronic inflammatory disease characterized by increased numbers of peritoneal macrophages and their secreted products. Inflammation plays a major role in pain and infertility associated with endometriosis, but is also extensively involved in the molecular processes that lead to peritoneal lesion development. Peritoneal oxidative stress is currently thought to be a major constituent of the endometriosis-associated inflammatory response. Excessive production of reactive oxygen species, secondary to peritoneal influx of pro-oxidants such as heme and iron during retrograde menstruation, may induce cellular damage and increased proinflammatory gene expression through nuclear factor-kappa B activation. In particular, prostaglandin biosynthetic enzyme expression is regulated by this transcriptional factor, and increased peritoneal prostaglandin concentrations have been demonstrated in endometriosis. In the light of available data collected from patient biopsies, as well as in vitro and in vivo studies, the respective involvement and potential molecular interactions of iron, nuclear factor-kappa B and prostaglandins in the pathogenesis of endometriosis are explored and discussed. The key role of peritoneal macrophages is emphasized and potential therapeutic targets are examined.


Subject(s)
Endometriosis/pathology , Inflammation/pathology , Peritoneal Diseases/pathology , Endometriosis/metabolism , Female , Humans , Inflammation/metabolism , Iron/metabolism , NF-kappa B/metabolism , Peritoneal Diseases/metabolism , Prostaglandins/metabolism
16.
Histol Histopathol ; 26(8): 1083-92, 2011 08.
Article in English | MEDLINE | ID: mdl-21692040

ABSTRACT

Endometriosis is a chronic pelvic inflammatory process. Local inflammation is known to play a role in pain and infertility associated with the disease, and may be extensively involved in molecular and cellular processes leading to endometriosis development. In this review, we focus on two inflammatory mediators clearly implicated in the pathogenesis of endometriosis, iron and NF-kappaB, and their potential association. Iron is essential for all living organisms, but excess iron results in toxicity and is linked to pathological disorders. In endometriosis patients, iron overload has been demonstrated in the different compartments of the peritoneal cavity (peritoneal fluid, endometriotic lesions, peritoneum and macrophages). This iron overload affects numerous mechanisms involved in endometriosis development. Moreover, iron can generate free radical species able to react with a wide range of cellular constituents, inducing cellular damage. Overproduction of reactive oxygen species also impairs cellular function by altering gene expression via regulation of redox-sensitive transcription factors such as NF-kappaB, which is clearly implicated in endometriosis. Indeed, NF-kappaB is activated in endometriotic lesions and peritoneal macrophages of endometriosis patients, which stimulates synthesis of proinflammatory cytokines, generating a positive feedback loop in the NF-kappaB pathway. NF-kappaB-mediated gene transcription promotes a variety of processes, including endometriotic lesion establishment, maintenance and development. In conclusion, iron and NF-kappaB appear to be linked and both are clearly involved in endometriosis development, making these pathways an attractive target for future treatment and prevention of this disease.


Subject(s)
Endometriosis/pathology , Inflammation/pathology , Iron Compounds/metabolism , NF-kappa B/metabolism , Peritoneal Diseases/pathology , Chronic Disease , Endometriosis/complications , Endometriosis/metabolism , Female , Humans , Inflammation/metabolism , Iron Overload/complications , Iron Overload/metabolism , Iron Overload/pathology , Peritoneal Diseases/complications , Peritoneal Diseases/metabolism , Peritoneum/metabolism , Peritoneum/pathology , Reactive Oxygen Species/metabolism
17.
Peptides ; 32(7): 1469-76, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21693141

ABSTRACT

Antimicrobial peptides (AMPs) are part of the innate immune system and are generally defined as cationic, amphipathic peptides, with less than 50 amino acids, including multiple arginine and lysine residues. The human cathelicidin antimicrobial peptide LL37 can be found at different concentrations in many different cells, tissues and body fluids and has a broad spectrum of antimicrobial and immunomodulatory activities. The healing of wound is a complex process that involves different steps: hemostasis, inflammation, remodeling/granulation tissue formation and re-epithelialization. Inflammation and angiogenesis are two fundamental physiological conditions implicated in this process. We have recently developed a new method for the expression and purification of recombinant LL37. In this work, we show that the recombinant peptide P-LL37 with a N-terminus proline preserves its immunophysiological properties in vitro and in vivo. P-LL37 neutralized the activation of macrophages by lipopolysaccharide (LPS). Besides, the peptide induced proliferation, migration and tubule-like structures formation by endothelial cells. Wound healing experiments were performed in dexamethasone-treated mice to study the effect of LL37 on angiogenesis and wound regeneration. The topical application of synthetic and recombinant LL37 increased vascularization and re-epithelialization. Taken together, these results clearly demonstrate that LL37 may have a key role in wound regeneration through vascularization.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cathelicidins/pharmacology , Endothelial Cells/drug effects , Neovascularization, Physiologic/drug effects , Recombinant Proteins/pharmacology , Soft Tissue Injuries/drug therapy , Wound Healing/drug effects , Animals , Anti-Bacterial Agents/chemistry , Antimicrobial Cationic Peptides , Cathelicidins/chemistry , Cell Movement/drug effects , Cell Survival/drug effects , Dexamethasone/adverse effects , Dexamethasone/pharmacology , Endothelial Cells/cytology , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Granulation Tissue/cytology , Granulation Tissue/drug effects , Granulation Tissue/physiology , Humans , Lipopolysaccharides/antagonists & inhibitors , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Mice , Mice, Inbred C57BL , Microscopy , Recombinant Proteins/chemistry , Soft Tissue Injuries/immunology , Soft Tissue Injuries/pathology , Wound Healing/physiology
18.
Fertil Steril ; 94(6): 1985-94, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20188363

ABSTRACT

OBJECTIVE: To evaluate the role of nuclear factor-κB (NF-κB) in the pathogenesis of endometriosis. DESIGN: A literature search was conducted in PubMed to identify all relevant citations. RESULT(S): Our findings highlight the important role of NF-κB in the pathophysiology of endometriosis. In vitro and in vivo studies show that NF-κB-mediated gene transcription promotes inflammation, invasion, angiogenesis, and cell proliferation and inhibits apoptosis of endometriotic cells. Constitutive activation of NF-κB has been demonstrated in endometriotic lesions and peritoneal macrophages of endometriosis patients. Agents blocking NF-κB are effective inhibitors of endometriosis development and some drugs with known NF-κB inhibitory properties have proved efficient at reducing endometriosis-associated symptoms in women. Iron overload activates NF-κB in macrophages. NF-κB activation in macrophages and ectopic endometrial cells stimulates synthesis of proinflammatory cytokines, generating a positive feedback loop in the NF-κB pathway and promoting endometriotic lesion establishment, maintenance and development. CONCLUSION(S): NF-κB transcriptional activity modulates key cell processes contributing to the initiation and progression of endometriosis. Because endometriosis is a multifactorial disease, inhibiting NF-κB appears to be a promising strategy for future therapies targeting different cell functions involved in endometriosis development, such as cell adhesion, invasion, angiogenesis, inflammation, proliferation, and apoptosis. Upcoming research will elucidate these hypotheses.


Subject(s)
Endometriosis/etiology , NF-kappa B/physiology , Uterine Diseases/etiology , Animals , Endometriosis/genetics , Endometriosis/immunology , Endometriosis/metabolism , Female , Humans , Inflammation/complications , Models, Biological , NF-kappa B/metabolism , Signal Transduction/genetics , Signal Transduction/physiology , Uterine Diseases/genetics , Uterine Diseases/immunology , Uterine Diseases/metabolism
19.
Protein Expr Purif ; 71(1): 1-7, 2010 May.
Article in English | MEDLINE | ID: mdl-19883767

ABSTRACT

The cathelicidin derived human peptide LL37 has a broad spectrum of antimicrobial and immunomodulatory activities. The large variety of biological activities makes LL37 a very promising candidate for clinical applications. The production of biologically active LL37 in large amounts with reduced costs can only be achieved using recombinant techniques. In this work, LL37 has been cloned to the N- and C-termini of a family III carbohydrate-binding module fused to the linker sequence (LK-CBM3) from Clostridium thermocellum; both constructions (LL37-LK-CBM3 and LK-CBM3-LL37) were cloned into the pET-21a vector. A formic acid recognition site was introduced between the two modules, allowing the isolation of LL37 after chemical cleavage. The recombinant proteins were expressed in Escherichia coli BL21 (DE3) and solubilized with Triton X-100. The purification was achieved using cellulose CF11 fibers, taking advantage of the CBM3 specific affinity for cellulose; after hydrolysis with formic acid, LL37 was further purified by reverse-phase HPLC, as confirmed by MALDI-TOF mass spectrometry. The production and purification methodology developed in this work compares advantageously to other protocols previously described, having fewer purification steps. Only the recombinant LL37 obtained from the C-terminally fused protein (LK-CBM3-LL37) showed antibacterial activity against E. coli K12, with a MIC of 180 microg/ml.


Subject(s)
Antimicrobial Cationic Peptides/isolation & purification , Antimicrobial Cationic Peptides/metabolism , Biochemistry/methods , Clostridium thermocellum/metabolism , Escherichia coli/metabolism , Receptors, Cell Surface/metabolism , Recombinant Fusion Proteins/isolation & purification , Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides/pharmacology , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Escherichia coli/drug effects , Microbial Sensitivity Tests , Recombinant Fusion Proteins/metabolism , Recombinant Fusion Proteins/pharmacology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Cathelicidins
20.
Fertil Steril ; 91(5): 1668-75, 2009 May.
Article in English | MEDLINE | ID: mdl-18396284

ABSTRACT

OBJECTIVE: To further investigate peritoneal iron disruption in endometriosis by studying iron storage in peritoneal macrophages of patients with endometriosis compared with controls. DESIGN: Cross-sectional study. SETTING: Academic gynecology research unit in a university hospital. PATIENT(S): Fifty patients undergoing laparoscopy. INTERVENTION(S): Collection of peritoneal fluid samples (N = 50) from patients with (n = 27) and without (n = 23) endometriosis undergoing laparoscopy. MAIN OUTCOME MEASURE(S): Quantification of peritoneal macrophage ferritin by immunocytochemical staining and immunodensitometry and measurement of peritoneal iron, transferrin, ferritin, and prohepcidin concentrations. RESULT(S): The optical density of peritoneal macrophage ferritin staining was statistically significantly higher in endometriosis patients than in controls. Higher iron concentrations, transferrin saturations, and ferritin concentrations were also detected in case of endometriosis. A statistically significant positive correlation was found between the optical density of macrophage ferritin staining and peritoneal iron concentrations in endometriosis and control patients. CONCLUSION(S): Iron storage is statistically significantly increased in peritoneal macrophages of patients with endometriosis and correlates with iron overload in peritoneal fluid. The potential implications of iron accumulation in peritoneal macrophages in case of endometriosis are discussed.


Subject(s)
Ascitic Fluid/metabolism , Endometriosis/metabolism , Iron Overload/metabolism , Iron/metabolism , Macrophages, Peritoneal/metabolism , Adult , Antimicrobial Cationic Peptides/analysis , Cross-Sectional Studies , Female , Ferritins/analysis , Hepcidins , Humans , Middle Aged , Protein Precursors/analysis , Transferrin/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...